Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial
- Llombart-Cussac, A.
- Prat, A.
- Pérez-García, J.M.
- Mateos, J.
- Pascual, T.
- Escrivà-de-Romani, S.
- Stradella, A.
- Ruiz-Borrego, M.
- de las Heras, B.B.
- Keyaerts, M.
- Galvan, P.
- Brasó-Maristany, F.
- García-Mosquera, J.J.
- Guiot, T.
- Gion, M.
- Sampayo-Cordero, M.
- Di Cosimo, S.
- Pérez-Escuredo, J.
- de Frutos, M.A.
- Cortés, J.
- Gebhart, G.
ISSN: 1619-7089, 1619-7070
Argitalpen urtea: 2024
Alea: 51
Zenbakia: 9
Orrialdeak: 2733-2743
Mota: Artikulua